Impact of non-hepatic hyperammonemia on mortality in intensive care unit patients: a retrospective cohort study
- Kim JH1,2
- Jeon H1,2
- Lee SS1,2,3
- Heo IR1,2
- Choi JW1
- Kim HJ1,2,3
- Cha RR1,2,3
- Lee JM1,2,3
- Kim HJ1,2,3
- Affiliations
-
- 1Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea
- 2Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea
- 3Institute of Health Sciences, Gyeongsang National University, Jinju, Korea
Abstract
- Background/Aims
The effect of hyperammonemia on the mortality in patients with liver cirrhosis is well documented. However, little is known about the impact of hyperammonemia on mortality among intensive care unit patients without hepatic disease. We aimed to investigate factors associated with non-hepatic hyperammonemia among intensive care unit patients and to evaluate the factors related to the 7- and 90-day mortality.
Methods
Between February 2016 and February 2020, 948 patients without hepatic disease who had 972 episodes of admission to the intensive care unit were retrospectively enrolled and classified as hyperammonemia grades 0 (≤ 80 µg/dL; 585 [60.2%]), 1 (≤ 160 µg/dL; 291 [29.9%]), 2 (≤ 240 µg/dL; 55 [5.7%]), and 3 (> 240 µg/dL; 41 [4.2%]). Factors associated with hyperammonemia and the 7- and 90-day mortality were evaluated by multivariate logistic regression analysis and Cox regression analysis, respectively. Kaplan-Meier survival curves for the 7- and 90-day mortality were constructed.
Results
The independent risk factors for hyperammonemia were male sex (odds ratio, 1.517), age (0.984/year), acute brain failure (2.467), acute kidney injury (1.437), prothrombin time-international normalized ratio (2.272/unit), and albumin (0.694/g/dL). The 90-day mortality rate in the entire cohort was 24.3% and gradually increased with increasing hyperammonemia grade at admission (17.9%, 28.2%, 43.6%, and 61.0% in patients with grades 0, 1, 2, and 3, respectively). Additionally, non-hepatic hyperammonemia was an independent predictor of the 90- day mortality in intensive care unit patients.
Conclusions
Non-hepatic hyperammonemia is common (39.8%) and associated with the 90-day mortality among intensive care unit patients.